Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23293756 | 0.90 | — | — | |
| SCHEMBL310725 | 0.81 | — | — | |
| SCHEMBL134560 | 0.74 | — | — | |
| SCHEMBL5546103 | 0.72 | — | — | |
| SCHEMBL4796430 | 0.72 | — | — | |
| SCHEMBL1498038 | 0.72 | — | — | |
| SCHEMBL11455598 | 0.72 | — | — | |
| SCHEMBL16693038 | 0.72 | — | — | |
| SCHEMBL1788916 | 0.72 | — | — | |
| SCHEMBL3697817 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326733-A1 | A NEW ROUTE FOR SYNTHESIZING AXIALLY CHIRAL CANNABINOIDS FROM COUMARINS | UNIV FLORIDA (US) | 2025-10-23 | — | — | US | disclosed |
| WO-2023108098-A1 | A NEW ROUTE FOR SYNTHESIZING AXIALLY CHIRAL CANNABINOIDS FROM COUMARINS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| CN-115466285-A | Multi-branched chain halophosphite, preparation method and application thereof | 恒大新能源技术(深圳)有限公司 | 2022-12-13 | — | — | CN | disclosed |
| US-5723631-A | Coumarin derivatives as retroviral inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1998-03-03 | — | — | US | disclosed |
| EP-0674643-A1 | COUMARIN DERIVATIVES AS RETROVIRAL INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-10-04 | — | — | EP | disclosed |
| EP-0674643-A4 | COUMARIN DERIVATIVES AS RETROVIRAL INHIBITORS. | SMITHKLINE BEECHAM CORP (US) | 1995-08-08 | — | — | EP | disclosed |
| WO-1994014789-A1 | COUMARIN DERIVATIVES AS RETROVIRAL INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-07-07 | — | — | WO | disclosed |
| US-4999371-A | Treating Cardiovascular Disorders | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-03-12 | — | — | US | disclosed |
| US-4153448-A | Novel (alkenyloxy)-, (alkynyloxy) and (cyanoalkoxy) alkoxyphenyl ureas and their use as herbicides | AMERICAN CYANAMID COMPANY (US) | 1979-05-08 | — | — | US | disclosed |
| US-4046808-A | (Alkenyloxy)-, (alkynyloxy) and (cyanoalkoxy) alkoxyphenyl ureas and their use as herbicides | AMERICAN CYANAMID COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326733-A1 | A NEW ROUTE FOR SYNTHESIZING AXIALLY CHIRAL CANNABINOIDS FROM COUMARINS | CNR1, CNR2, CBR3 | ELANE 4376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.